Page 2 - Interferon Beta News Today

The Business Research Companys Coronavirus (COVID-19) Current Therapy Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

The Business Research Company’s Coronavirus (COVID-19) Current Therapy Global Market Report 2022 – Market Size, Trends, And Forecast 2022-2026

Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players

The Business Research Company’s Coronavirus (COVID-19) Current Therapy Global Market Report 2022: Market Size, Trends, And Forecast To 2026

Vancouver, British Columbia--(Newsfile Corp. - March 25, 2022) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and investment

Visiongain has published a new report on Multiple Sclerosis Drugs Market Report 2021-2031:Forecasts By Drug Class (Corticosteroids, Interferon Beta,...

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2021) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and

Biocure Technology Inc.: BioCure Technology Inc. Announces Closing of Financing Vancouver, British Columbia--(Newsfile Corp. - July 14, 2021) - BioCure Technology Inc. (CSE: CURE) ("BioCure" or the "Company") announces that it has successfully closed a non-brokered private placement (the "Private Placement") consisting of 6,706,525 Units at a price of $0.16 cents per Unit for gross proceeds of $1,073,044.00 Each Unit is comprised of one common share (the "Shares") and one share purchase warrant...

Vaccines have received all the attention but they are not humanity’s only weapon against coronavirus: we also have treatments. One is made by Synairgen, whose Covid-19 remedy consists of a naturally occurring antiviral protein, interferon beta, that is delivered directly to where it counts: the patient’s lungs. While we all hope the vaccines will provide our path out of the pandemic there remains the fear that vaccine-resistant variants will allow the virus to stay one step ahead. ...

UK, with high hopes of helping Covid-19 patients stop developing serious illness. The new treatment involves inhaling a protein called Interferon Beta, which the body produces in infection. The hope is that this will stimulate the immune system and the cells will be prepared to fight viruses. Initial results from the trials showed that treatment reduced by nearly 80 percent the chances of patients in hospital with Covid-19 developing severe diseases. Results from phase two trials of around 100 ...